As the IPO market heats up, three notable IPOs listing on Monday. These IPOs are: Senores Pharmaceuticals, Ventive Hospitality, and Carraro India. Each of these IPOs presents distinct opportunities and challenges, particularly highlighted by their respective grey market premiums (GMP). Here is a closer look at each IPOs GMPs, subscription rates, and estimated listing prices ahead of their listing on Monday, 30 December 2024.
IPOs Listing on Monday
Senores Pharmaceuticals IPO
Senores Pharmaceuticals is set to make its debut with shares expected to list on 30 December 2024, at BSE and NSE. The IPO was priced within a band of INR 372 to INR 391 per share, aiming to raise approximately INR 582.11 crores. As of 27 December 2024, the GMP stands at INR 240, suggesting an estimated listing price of around INR 631 per share. This indicates a potential listing gain of over 61% from the upper end of the IPO price.
Subscription Status
The subscription figures for Senores Pharmaceuticals are quite impressive, showcasing strong demand across various investor categories:
| Category | QIB (X) | NII (X) | Retail (X) | Emp (X) | Total (X) |
| Shares Offered | 45,93,216 | 23,19,879 | 15,46,586 | 75,000 | 85,34,681 |
| Last Day | 94.66 | 96.11 | 89.22 | 19.92 | 93.41 |
This overwhelming response indicates strong investor confidence in the company’s future prospects.
Ventive Hospitality IPO Overview
Blackstone-backed Ventive Hospitality is another strong player set to list in the final days of 2024. The company aims to raise INR 1,600 crores through its offering, priced between INR 610 and INR 643 per share. As of 27 December 2024, the GMP for Ventive Hospitality stands at INR 65 per share, indicating that the stock is likely to list in positive territory, with an anticipated listing price of approximately INR 708 per share.
Subscription Status
The subscription details reveal varied interest levels among different investor categories:
| Category | QIB (X) | NII (X) | Retail (X) | Emp (X) | Total (X) |
| Shares Offered | 78,63,934 | 39,31,967 | 26,21,311 | 17,241 | 1,44,34,453 |
| Last Day | 9.08 | 13.85 | 5.87 | 9.49 | 9.80 |
Despite lower overall subscription rates compared to Senores Pharmaceuticals, Ventive Hospitality still holds promise for investors looking for growth in the hospitality sector.
Carraro India IPO: A Cautious Approach
In contrast to its counterparts, Carraro India has not garnered any GMP as of now. The IPO is priced between INR 668 and INR 704 per share in a bid to raise INR 1,250 crores entirely through an offer-for-sale mechanism. The absence of GMP suggests cautious sentiment among investors.
Subscription Status
The subscription figures for Carraro India reflect limited interest:
| Category | QIB (X) | NII (X) | Retail (X) | Total (X) |
| Shares Offered | 37,42,515 | 28,06,887 | 65,49,401 | 1,30,98,803 |
| Last Day | 2.21 | 0.60 | 0.71 | 1.12 |
The low subscription rates may indicate investor hesitance or a wait-and-see approach regarding Carraro India’s market potential.
Conclusion
As we approach the listing dates of IPOs, investors are keenly observing the market dynamics shaped by GMPs and subscription rates. These IPOs listing on Monday promise substantial returns based on current trends. Meanwhile, Ventive Hospitality offers moderate potential with its upcoming listing while Carraro India remains a cautious choice amidst uncertain market sentiment.
Nevertheless, the long-term performance of IPOs is largely independent of its listing. There have been several instances of IPOs which were either misunderstood by the market or received low subscription due to market conditions but went on to reward investors after listing. For eg. Zinka Logistics Solutions and Sagility India stocks have shown remarkable returns following their market debut.
